Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2003
03/13/2003US20030049324 Using aqueous solution of water soluble antibiotic and surfactant; vaporizatio, evaportaion of water; forming deposits
03/13/2003US20030049323 Mixing, dissolving, circulation with nonsolvent, slurrying;uniformity
03/13/2003US20030049322 Aqueous-based pharmaceutical composition
03/13/2003US20030049321 Process for producing fine medicinal substances
03/13/2003US20030049320 Novel in-situ forming controlled release microcarrier delivery system
03/13/2003US20030049319 Once a day antihistamine and decongestant formulation
03/13/2003US20030049318 Sustained release formulations of guaifenesin and additional drug ingredients
03/13/2003US20030049317 Mixture of sustained release active drug and antagonist if drug is chewed
03/13/2003US20030049316 Mixture containing carbohydrate and binder
03/13/2003US20030049315 Blending wih starch, lubricant, wetting agent; compression
03/13/2003US20030049314 Mixture of anticholesterol agent, enzyme inhibitor and aspirin
03/13/2003US20030049313 Dietary fiber delivery system
03/13/2003US20030049312 Pressing; shaping into ribbons
03/13/2003US20030049311 Pharmaceutical formulation
03/13/2003US20030049310 Genetic enginnering; inducing antibodies
03/13/2003US20030049309 Veterinary compositions for the treatment of parasitic diseases
03/13/2003US20030049308 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication
03/13/2003US20030049307 Pharmaceutical composition
03/13/2003US20030049304 Quiescently frozen ice products
03/13/2003US20030049302 Anticancer agent in intravagina device
03/13/2003US20030049301 Crosslinking collage
03/13/2003US20030049298 Use of microparticles with adsorbed antigen to stimulate immune responses
03/13/2003US20030049289 Cosmetic or dermatological preparations of the oil-in-water type
03/13/2003US20030049281 Topical emulsion; quaternary ammonium salt emulsifier
03/13/2003US20030049280 Spontaneous emulsions containing cyclosporine
03/13/2003US20030049279 Polysaccharide encapsualted antigen
03/13/2003US20030049272 Therapy for drug abruse; administering central nervous stimulant and mucous membrane irritation
03/13/2003US20030049256 Cytokine antagonists for neurological and neuropsychiatric disorders
03/13/2003US20030049247 Pharmaceutical composition comprising carriers for products based on vitamin-e, pa pain and hyaluronidase
03/13/2003US20030049245 Methods for sterilizing preparations of digestive enzymes
03/13/2003US20030049242 Decorated red blood cells
03/13/2003US20030049224 Hair treatment gels containing itaconic acid monoester/acrylate copolymer
03/13/2003US20030049209 Sustained-release matrices for dental application
03/13/2003US20030049208 For delivering a medicant; product includes a coating having a medicament or agent; bioavailabilty; chewing gum product that releases caffiene for improved performance
03/13/2003US20030049158 Stablization and terminal sterilization of phospholipid formulations
03/13/2003US20030047824 Method and apparatus for the formation of particles
03/13/2003US20030047186 Disposable personal aromatherapy mask kit
03/13/2003CA2833997A1 Method and apparatus for nitric oxide generation
03/13/2003CA2459891A1 Method and apparatus for nitric oxide generation
03/13/2003CA2459796A1 Homing peptides
03/13/2003CA2458995A1 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003CA2458963A1 Increased solubility flavanolignan preparations
03/13/2003CA2458682A1 Nanoparticles comprising biologically active tnf which is immobilised on the same
03/13/2003CA2458644A1 Crystaline clindamycin free base
03/13/2003CA2457926A1 Pharmaceutical compositions for the treatment of asthma
03/13/2003CA2457538A1 Stabilizing catheter for protein drug delivery
03/13/2003CA2457526A1 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
03/13/2003CA2456904A1 Aerosolized decongestants for the treatment of sinusitis
03/12/2003EP1291588A1 Humidity augmenting apparatus
03/12/2003EP1291362A1 A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1291322A1 Process for increasing the moisture content in a dehydrated matter
03/12/2003EP1291025A2 Medical adhesive composition, medical adhesive tape using the same and tape preparation for percutaneous absorption
03/12/2003EP1291023A1 Sustained release compositions
03/12/2003EP1291021A2 Pharmaceutical formulations for thyroid hormones
03/12/2003EP1291019A1 Biologically active agents and drugs
03/12/2003EP1291015A1 Dosage forms having prolonged active ingredient release
03/12/2003EP1291014A1 A process for producing a pharmaceutical solid preparation containing a poorly soluble drug
03/12/2003EP1291013A2 Storage-stable pharmaceutical compositions
03/12/2003EP1290996A2 Single-dose pack of substances which cure by absorption or contact
03/12/2003EP1290930A1 Process for germinating plant seeds and growing a seedling
03/12/2003EP1290231A1 Two-hybrid assay that detects hiv-1 reverse transcriptase dimerization
03/12/2003EP1290204A1 Antisense modulation of c/ebp alpha expression
03/12/2003EP1290153A2 Molecular delivery vehicle for delivery of selected compounds to targets
03/12/2003EP1290024A1 Glucose dependent release of insulin from glucose sensing insulin derivatives
03/12/2003EP1289931A1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
03/12/2003EP1289740A1 Crystalline polymeric compositions for ophthalmic devices
03/12/2003EP1289645A2 Zero order release and temperature-controlled microcapsules and process for the preparation thereof
03/12/2003EP1289642A1 Nanocapsules having a polyelectrolyte envelope
03/12/2003EP1289573A1 A medicinal aerosol formulation
03/12/2003EP1289570A1 Liposomal encapsulation of chelated actinium-225 and uses thereof
03/12/2003EP1289567A2 Lyophilizable and enhanced compacted nucleic acids
03/12/2003EP1289560A1 Novel solid dispersion compositions
03/12/2003EP1289547A2 Immunization through oral administration of a vaccine with an edible product
03/12/2003EP1289543A2 Formulations and methods for treating hypercoagulable states
03/12/2003EP1289542A1 Means for maintenance and/or correction of glucose concentration in blood
03/12/2003EP1289540A2 Methods and compositions for producing a neurosalutary effect in a subject
03/12/2003EP1289539A1 Pharmaceutical anti-inflammatory aerosol formulation
03/12/2003EP1289536A2 Apoptotic entities for use in treatment of endothelium dysfunction disorders
03/12/2003EP1289534A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
03/12/2003EP1289532A2 Low carbohydrate compositions, kits thereof, and methods of use
03/12/2003EP1289531A2 Kits and methods for optimizing the efficacy of chondroprotective compositions
03/12/2003EP1289530A1 Lipids for modulating immune response
03/12/2003EP1289529A1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
03/12/2003EP1289528A1 Active substance combination containing an opioid having a fentanyl-type structure and ketamine
03/12/2003EP1289524A2 Porous celecoxib matrices and methods of manufacture thereof
03/12/2003EP1289518A2 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent
03/12/2003EP1289517A2 Pharmaceutical compositions comprising cannabidiol derivatives
03/12/2003EP1289515A1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof
03/12/2003EP1289510A2 Compositions, kits, and methods for promoting defined health benefits
03/12/2003EP1289506A1 Novel composition
03/12/2003EP1289505A1 Novel process
03/12/2003EP1289504A2 Neurotoxin implant
03/12/2003EP1289503A2 O/w emulsion
03/12/2003EP1289502A1 Microemulsion preconcentrates, microemulsion and use of such a composition
03/12/2003EP1289501A1 Novel aqueous anti-inflammatory pharmaceutical formulation
03/12/2003EP1289500A1 Novel pharmaceutical formulation suitable for nebulisation
03/12/2003EP1289499A1 Pharmaceutical anti-inflammatory aerosol formulation
03/12/2003EP1289498A1 Novel pharmaceutical formulation suitable for nebulisation
03/12/2003EP1289497A1 Novel aqueous anti-inflammatory pharmaceutical formulation
1 ... 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 ... 2991